OTCMKTS:PBIO Pressure BioSciences 2/7/2025 Earnings Report $0.0003 0.00 (0.00%) As of 09/19/2025 ProfileEarnings History Pressure BioSciences EPS ResultsActual EPS-$0.15Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/APressure BioSciences Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/APressure BioSciences Announcement DetailsQuarterDate2/7/2025TimeAfter Market ClosesConference Call DateN/AConference Call TimeN/AConference Call ResourcesEarnings HistoryCompany Profile Pressure BioSciences Earnings HeadlinesComparing Envoy Medical (NASDAQ:COCH) & Pressure BioSciences (OTCMKTS:PBIO)September 16, 2025 | americanbankingnews.comPressure BioSciences Partners with Vita-Forte, Largest Global Supplier of Freeze-Dried Acai, to Commercialize Highly Potent, Multi-Antioxidant, UST Nanoemulsion Oral SprayJune 25, 2024 | globenewswire.comMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.September 22 at 2:00 AM | American Alternative (Ad)Pressure BioSciences, Inc. to Host Business and Financial Update on Thursday, June 20th at 4:30pm ETJune 18, 2024 | globenewswire.comPressure BioSciences, Inc. to Host Business and Financial Update on Wednesday, June 19th at 4:30pm ETJune 13, 2024 | globenewswire.comThe big blood pressure experimentApril 24, 2024 | bbc.co.ukSee More Pressure BioSciences Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Pressure BioSciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Pressure BioSciences and other key companies, straight to your email. Email Address About Pressure BioSciencesPressure BioSciences (OTCMKTS:PBIO), Inc., headquartered in South Easton, Massachusetts, develops and markets novel pressure-based instruments and consumables for sample preparation in the life sciences, biotechnology and pharmaceutical industries. The company’s core innovation, Pressure Cycling Technology (PCT), uses alternating cycles of high hydrostatic pressure to facilitate efficient and reproducible cell disruption, protein extraction and subcellular fractionation. Its flagship Barocycler® instrument has been adopted by researchers working in proteomics, biomarker discovery, vaccine development and pathogen inactivation workflows. In addition to its instrument platform, Pressure BioSciences offers a range of proprietary consumables—including pressure-resistant processing tubes and optimized reagent kits—designed to support diverse sample types such as tissue, microbes and blood derivatives. The company also markets an Ultra Shear Technology (UST) system for high-pressure homogenization, targeting applications in food science, nutraceutical development and personal care product formulation. Pressure BioSciences serves a global customer base through direct sales and distribution partners in North America, Europe and Asia. Its clients include academic and government research institutions, contract research organizations and biotechnology and pharmaceutical companies. Although it operates as a small-cap public company on the OTC markets, the firm has established collaborative relationships with leading research centers and regularly showcases its sample-preparation solutions at scientific conferences and trade exhibitions.View Pressure BioSciences ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Berkshire-Backed Lennar Slides After Weak Q3 EarningsWall Street Eyes +30% Upside in Synopsys After Huge Earnings FallRH Stock Slides After Mixed Earnings and Tariff ConcernsCelsius Stock Surges After Blowout Earnings and Pepsi DealWhy DocuSign Could Be a SaaS Value Play After Q2 EarningsWhy Broadcom's Q3 Earnings Were a Huge Win for AVGO BullsAffirm Crushes Earnings Expectations, Turns Bears into Believers Upcoming Earnings Micron Technology (9/23/2025)AutoZone (9/23/2025)Cintas (9/24/2025)Costco Wholesale (9/25/2025)Accenture (9/25/2025)NIKE (9/30/2025)PepsiCo (10/9/2025)BlackRock (10/10/2025)Fastenal (10/13/2025)Citigroup (10/14/2025) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.